Safety of IL-17A inhibitors in 306 psoriasis patients with or without latent tuberculosis

Published: 21 August 2024| Version 1 | DOI: 10.17632/r63vzzcxz4.1
Contributor:
yizhang liu

Description

The research results found that after 48 weeks of IL-17A inhibitor treatment, IFN - γ levels in psoriasis patients increased compared to baseline. Adequate prophylactic anti tuberculosis treatment for LTBI patients can help prevent an increase in IFN - γ levels and did not affect the efficacy and safety of IL-17A inhibitors.

Files

Institutions

Xiangya Hospital Central South University

Categories

Psoriasis

Funding

National Key Research and Development Program of China

2023YFC2508105

National Natural Science Foundation of China

82373484, 82073447, 82003354, 82221002, 82130090, 82003362

Licence